Cargando…
Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease
Autores principales: | Toor, Devinder, Jain, Aklank, Kalhan, Shivani, Manocha, Harmesh, Sharma, Vivek Kumar, Jain, Payal, Tripathi, Vishwas, Prakash, Hridayesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596271/ https://www.ncbi.nlm.nih.gov/pubmed/33178021 http://dx.doi.org/10.3389/fphar.2020.570698 |
Ejemplares similares
-
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
por: Roy, Roshan Kumar, et al.
Publicado: (2021) -
Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity
por: Nadella, Vinod, et al.
Publicado: (2020) -
Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease
por: Prakash, Hridayesh, et al.
Publicado: (2021) -
The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
por: Malhotra, Akshay, et al.
Publicado: (2017) -
A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response
por: Sharma, Uttam, et al.
Publicado: (2022)